NO991761L - Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse - Google Patents
Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelseInfo
- Publication number
- NO991761L NO991761L NO991761A NO991761A NO991761L NO 991761 L NO991761 L NO 991761L NO 991761 A NO991761 A NO 991761A NO 991761 A NO991761 A NO 991761A NO 991761 L NO991761 L NO 991761L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- acid derivatives
- cotocarboxylic
- new piperidine
- piperidine
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19642591A DE19642591A1 (de) | 1996-10-15 | 1996-10-15 | Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung |
| PCT/EP1997/005202 WO1998016512A1 (de) | 1996-10-15 | 1997-09-23 | Neue piperidin-ketocarbonsäure-derivate, deren herstellung und anwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO991761D0 NO991761D0 (no) | 1999-04-14 |
| NO991761L true NO991761L (no) | 1999-04-14 |
Family
ID=7808858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO991761A NO991761L (no) | 1996-10-15 | 1999-04-14 | Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6380220B1 (tr) |
| EP (1) | EP0934273A1 (tr) |
| JP (1) | JP2001501955A (tr) |
| KR (1) | KR20000049130A (tr) |
| CN (1) | CN1239950A (tr) |
| AR (1) | AR009379A1 (tr) |
| AU (1) | AU736754B2 (tr) |
| BG (1) | BG103338A (tr) |
| BR (1) | BR9711908A (tr) |
| CA (1) | CA2268917A1 (tr) |
| CO (1) | CO4930264A1 (tr) |
| CZ (1) | CZ126899A3 (tr) |
| DE (1) | DE19642591A1 (tr) |
| HR (1) | HRP970549A2 (tr) |
| HU (1) | HUP9904104A3 (tr) |
| IL (1) | IL129089A0 (tr) |
| NO (1) | NO991761L (tr) |
| NZ (1) | NZ334979A (tr) |
| PL (1) | PL332720A1 (tr) |
| RU (1) | RU2189974C2 (tr) |
| SK (1) | SK38599A3 (tr) |
| TR (1) | TR199900819T2 (tr) |
| WO (1) | WO1998016512A1 (tr) |
| ZA (1) | ZA979175B (tr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3819099A (en) | 1998-04-20 | 1999-11-08 | Basf Aktiengesellschaft | Heterocyclically substituted amides used as calpain inhibitors |
| JP2002512240A (ja) * | 1998-04-20 | 2002-04-23 | ビーエーエスエフ アクチェンゲゼルシャフト | 複素環式置換基を有する新規アミド、その製造方法およびその使用 |
| DE19817459A1 (de) | 1998-04-20 | 1999-10-21 | Basf Ag | Neue heterozyklische substituierte Amide, Herstellung und Anwendung |
| TR200003068T2 (tr) | 1998-04-20 | 2001-03-21 | Basf Aktiengesellschaft | Yeni amidler, üretimi ve kullanımı |
| US6117870A (en) * | 1998-11-12 | 2000-09-12 | Fujirebio Kabushiki Kaisha | Cyclic amide derivatives |
| WO2001014331A2 (en) * | 1999-08-24 | 2001-03-01 | Regents Of The University Of California | Non-quinoline inhibitors of malaria parasites |
| WO2001023376A1 (en) | 1999-09-29 | 2001-04-05 | Ortho-Mcneil Pharmaceutical, Inc. | Isonipecotamides for the treatment of integrin-mediated disorders |
| CA2414960C (en) | 2000-06-30 | 2012-04-10 | Seikagaku Corporation | Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing .alpha.keto amide compound using them |
| DE10114762A1 (de) * | 2001-03-26 | 2002-10-02 | Knoll Gmbh | Verwendung von Cysteinprotease-Inhibitoren |
| WO2002081467A1 (en) | 2001-04-09 | 2002-10-17 | Ortho-Mcneil Pharmaceutical, Inc. | Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| JP4617449B2 (ja) | 2002-07-11 | 2011-01-26 | ヴィキュロン ファーマシューティカルズ インコーポレイテッド | 抗菌活性を有するn−ヒドロキシアミド誘導体 |
| WO2005019177A1 (en) * | 2003-08-14 | 2005-03-03 | Icos Corporation | Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof |
| KR20070008517A (ko) * | 2003-10-24 | 2007-01-17 | 아벤티스 파마슈티칼스 인크. | 카텝신 저해물질로서 신규한 케토-옥사디아졸 유도체 |
| JP5295976B2 (ja) | 2006-12-29 | 2013-09-18 | アボット ゲーエムベーハー ウント カンパニー カーゲー | カルボキサミド化合物およびカルパイン阻害剤としてのこれらの使用 |
| TWI453019B (zh) * | 2007-12-28 | 2014-09-21 | Abbvie Deutschland | 甲醯胺化合物 |
| TWI519530B (zh) | 2009-02-20 | 2016-02-01 | 艾伯維德國有限及兩合公司 | 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途 |
| US8236798B2 (en) | 2009-05-07 | 2012-08-07 | Abbott Gmbh & Co. Kg | Carboxamide compounds and their use as calpain inhibitors |
| US9051304B2 (en) * | 2009-12-22 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors V |
| US8598211B2 (en) | 2009-12-22 | 2013-12-03 | Abbvie Inc. | Carboxamide compounds and their use as calpain inhibitors IV |
| US9062027B2 (en) | 2010-12-09 | 2015-06-23 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors V |
| JP2015512427A (ja) | 2012-04-03 | 2015-04-27 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | カルボキサミド化合物およびそれのカルパイン阻害薬vとしての使用 |
| WO2017156071A1 (en) | 2016-03-09 | 2017-09-14 | Blade Therapeutics, Inc. | Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof |
| WO2018009417A1 (en) | 2016-07-05 | 2018-01-11 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
| WO2018064119A1 (en) | 2016-09-28 | 2018-04-05 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
| JP7269875B2 (ja) | 2017-06-01 | 2023-05-09 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピラゾロキノリン誘導体を含有するレビー小体病治療剤 |
| SG11201909359YA (en) | 2017-06-01 | 2019-11-28 | Eisai R&D Man Co Ltd | Pharmaceutical composition comprising pde9 inhibitor |
| SG11202008750XA (en) * | 2018-03-28 | 2020-10-29 | Blade Therapeutics Inc | Calpain modulators and therapeutic uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8904298D0 (sv) * | 1989-12-21 | 1989-12-21 | Astra Ab | New compounds |
| CA2098702A1 (en) | 1990-12-28 | 1992-06-29 | James C. Powers | Peptide ketoamides, ketoacids, and ketoesters |
| CA2098609A1 (en) * | 1990-12-28 | 1992-06-29 | Raymond T. Bartus | Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
| CA2071621C (en) * | 1991-06-19 | 1996-08-06 | Ahihiko Hosoda | Aldehyde derivatives |
| JPH09500087A (ja) | 1992-06-24 | 1997-01-07 | コーテックス ファーマシューティカルズ インコーポレイテッド | カルパイン活性の増大に関連した健康障害の抑制及び処置におけるカルパイン阻害剤の使用法 |
| US5541290A (en) * | 1993-06-24 | 1996-07-30 | Harbeson; Scott L. | Optically pure calpain inhibitor compounds |
-
1996
- 1996-10-15 DE DE19642591A patent/DE19642591A1/de not_active Withdrawn
-
1997
- 1997-09-23 US US09/284,543 patent/US6380220B1/en not_active Expired - Fee Related
- 1997-09-23 CZ CZ991268A patent/CZ126899A3/cs unknown
- 1997-09-23 NZ NZ334979A patent/NZ334979A/en unknown
- 1997-09-23 CA CA002268917A patent/CA2268917A1/en not_active Abandoned
- 1997-09-23 CN CN97180507A patent/CN1239950A/zh active Pending
- 1997-09-23 SK SK385-99A patent/SK38599A3/sk unknown
- 1997-09-23 BR BR9711908A patent/BR9711908A/pt unknown
- 1997-09-23 HU HU9904104A patent/HUP9904104A3/hu unknown
- 1997-09-23 WO PCT/EP1997/005202 patent/WO1998016512A1/de not_active Ceased
- 1997-09-23 RU RU99109969/04A patent/RU2189974C2/ru active
- 1997-09-23 AU AU47770/97A patent/AU736754B2/en not_active Ceased
- 1997-09-23 PL PL97332720A patent/PL332720A1/xx unknown
- 1997-09-23 KR KR1019990703216A patent/KR20000049130A/ko not_active Withdrawn
- 1997-09-23 JP JP10517955A patent/JP2001501955A/ja active Pending
- 1997-09-23 EP EP97910332A patent/EP0934273A1/de not_active Withdrawn
- 1997-09-23 IL IL12908997A patent/IL129089A0/xx unknown
- 1997-09-23 TR TR1999/00819T patent/TR199900819T2/tr unknown
- 1997-10-14 AR ARP970104718A patent/AR009379A1/es not_active Application Discontinuation
- 1997-10-14 CO CO97060053A patent/CO4930264A1/es unknown
- 1997-10-14 ZA ZA979175A patent/ZA979175B/xx unknown
- 1997-10-14 HR HR19642591,3A patent/HRP970549A2/hr not_active Application Discontinuation
-
1999
- 1999-04-14 NO NO991761A patent/NO991761L/no not_active Application Discontinuation
- 1999-04-15 BG BG103338A patent/BG103338A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ334979A (en) | 2001-02-23 |
| CZ126899A3 (cs) | 1999-07-14 |
| CA2268917A1 (en) | 1998-04-23 |
| NO991761D0 (no) | 1999-04-14 |
| ZA979175B (en) | 1999-04-14 |
| CN1239950A (zh) | 1999-12-29 |
| IL129089A0 (en) | 2000-02-17 |
| BR9711908A (pt) | 1999-08-24 |
| TR199900819T2 (tr) | 1999-06-21 |
| CO4930264A1 (es) | 2000-06-27 |
| AU736754B2 (en) | 2001-08-02 |
| KR20000049130A (ko) | 2000-07-25 |
| US6380220B1 (en) | 2002-04-30 |
| DE19642591A1 (de) | 1998-04-16 |
| WO1998016512A1 (de) | 1998-04-23 |
| BG103338A (bg) | 2000-01-31 |
| HUP9904104A2 (hu) | 2000-05-28 |
| HRP970549A2 (en) | 1998-08-31 |
| EP0934273A1 (de) | 1999-08-11 |
| PL332720A1 (en) | 1999-10-11 |
| AU4777097A (en) | 1998-05-11 |
| RU2189974C2 (ru) | 2002-09-27 |
| JP2001501955A (ja) | 2001-02-13 |
| HUP9904104A3 (en) | 2001-01-29 |
| SK38599A3 (en) | 2000-04-10 |
| AR009379A1 (es) | 2000-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO991761L (no) | Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse | |
| NO992821L (no) | Ketobenzamider som calpain-inhibitorer | |
| NO20006282L (no) | Nye cyklosporiner | |
| NO20012158L (no) | Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav | |
| NO974236L (no) | Disubstituerte 1,4-piperidinestere og amider som har 5-HT4antagonistisk aktivitet | |
| NO20035210L (no) | 2-anilino-pyrimidinderivater som cyklinavhengige kinaseinhibitorer | |
| NO20075065L (no) | Anvendelse av isoflavonforbindelser til a behandle hjertesykdom | |
| NO20021328L (no) | Pyrazolopyrimidier som terapeutiske midler | |
| NO20050828L (no) | lndol-3-svovelderivater | |
| NO20000841L (no) | N-Aroylfenylalanin-derivater | |
| GEP20053470B (en) | N-Heteroaryl-Pyridinesulfonamide Derivatives and Their Use as Endothelin Antagonists | |
| NO991732L (no) | Nye heterocyklylmetylsubstituerte pyrazolderivater | |
| NO992400L (no) | Nye substituerte pyrazolderivater | |
| NO20002958L (no) | Benzamidinderivater som koagulasjonsfaktor Xa-hemmere | |
| DE60045508D1 (de) | Dalda-analoge und ihre verwendung | |
| NO20002702L (no) | Tienopyrimidiner | |
| NO20050087L (no) | N-benzoylureido-kanelsyrederivater, fremgangsmate for fremstilling og anvendelse av disse | |
| DK0888327T3 (da) | Benzopyranderivater, som har antagonistisk virkning imod leukotriener | |
| NO20052487L (no) | 1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater. | |
| NO20052182L (no) | Nye forbindelser | |
| NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
| NO20001934L (no) | 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse | |
| TR199700206A2 (tr) | Floralkil- ve floralkoksi ikame edilmis heterosiklik bradikinin-antagonistleri, bunlarin imal edilmesine mahsus usul ve bunlarin kullanilmalari. | |
| NO20023001L (no) | Substituerte piperazinderivater som MTP inhibitorer | |
| NO20022123L (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |